Kiaro Holdings Corp.
Kiaro Holdings Corp. KIARF Peers
See (KIARF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KIARF | $0.01 | N/A | 66.58M | -0.01 | -$0.47 | N/A |
| CLCGY | $42.26 | -0.98% | 20.03B | 30.19 | $1.40 | +0.09% |
| ALBBY | $14.00 | N/A | 11.26B | 63.64 | $0.22 | N/A |
| ALBHF | $0.67 | +0.02% | 10.71B | 66.60 | $0.01 | N/A |
| MSMKF | $18.11 | +0.03% | 7.31B | 19.68 | $0.92 | +1.66% |
| DCHPF | $46.90 | -0.21% | 5.34B | -151.29 | -$0.31 | N/A |
| RGEDF | $27.17 | +0.01% | 4.97B | 7.99 | $3.40 | N/A |
| RADLY | $2.64 | +1.54% | 4.57B | 20.31 | $0.13 | +0.40% |
| GEDSF | $24.85 | +0.00% | 4.54B | 10.71 | $2.32 | +4.70% |
| CSMYF | $46.06 | N/A | 3.65B | 19.77 | $2.33 | +0.89% |
Stock Comparison
KIARF vs CLCGY Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, CLCGY has a market cap of 20.03B. Regarding current trading prices, KIARF is priced at $0.01, while CLCGY trades at $42.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas CLCGY's P/E ratio is 30.19. In terms of profitability, KIARF's ROE is -1.47%, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, KIARF is less volatile compared to CLCGY. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs ALBBY Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, ALBBY has a market cap of 11.26B. Regarding current trading prices, KIARF is priced at $0.01, while ALBBY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas ALBBY's P/E ratio is 63.64. In terms of profitability, KIARF's ROE is -1.47%, compared to ALBBY's ROE of +0.06%. Regarding short-term risk, KIARF is less volatile compared to ALBBY. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs ALBHF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, ALBHF has a market cap of 10.71B. Regarding current trading prices, KIARF is priced at $0.01, while ALBHF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas ALBHF's P/E ratio is 66.60. In terms of profitability, KIARF's ROE is -1.47%, compared to ALBHF's ROE of +0.06%. Regarding short-term risk, KIARF is less volatile compared to ALBHF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs MSMKF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, MSMKF has a market cap of 7.31B. Regarding current trading prices, KIARF is priced at $0.01, while MSMKF trades at $18.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas MSMKF's P/E ratio is 19.68. In terms of profitability, KIARF's ROE is -1.47%, compared to MSMKF's ROE of +0.07%. Regarding short-term risk, KIARF is less volatile compared to MSMKF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs DCHPF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, DCHPF has a market cap of 5.34B. Regarding current trading prices, KIARF is priced at $0.01, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, KIARF's ROE is -1.47%, compared to DCHPF's ROE of N/A. Regarding short-term risk, KIARF and DCHPF have similar daily volatility (0.00).
KIARF vs RGEDF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, RGEDF has a market cap of 4.97B. Regarding current trading prices, KIARF is priced at $0.01, while RGEDF trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas RGEDF's P/E ratio is 7.99. In terms of profitability, KIARF's ROE is -1.47%, compared to RGEDF's ROE of +0.20%. Regarding short-term risk, KIARF is less volatile compared to RGEDF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs RADLY Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, RADLY has a market cap of 4.57B. Regarding current trading prices, KIARF is priced at $0.01, while RADLY trades at $2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas RADLY's P/E ratio is 20.31. In terms of profitability, KIARF's ROE is -1.47%, compared to RADLY's ROE of +0.18%. Regarding short-term risk, KIARF is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs GEDSF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, GEDSF has a market cap of 4.54B. Regarding current trading prices, KIARF is priced at $0.01, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, KIARF's ROE is -1.47%, compared to GEDSF's ROE of +0.15%. Regarding short-term risk, KIARF and GEDSF have similar daily volatility (0.00).
KIARF vs CSMYF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, CSMYF has a market cap of 3.65B. Regarding current trading prices, KIARF is priced at $0.01, while CSMYF trades at $46.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas CSMYF's P/E ratio is 19.77. In terms of profitability, KIARF's ROE is -1.47%, compared to CSMYF's ROE of +0.08%. Regarding short-term risk, KIARF is less volatile compared to CSMYF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs WLCGF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, WLCGF has a market cap of 3.41B. Regarding current trading prices, KIARF is priced at $0.01, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, KIARF's ROE is -1.47%, compared to WLCGF's ROE of +0.09%. Regarding short-term risk, KIARF and WLCGF have similar daily volatility (0.00).
KIARF vs SDGCF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SDGCF has a market cap of 3.30B. Regarding current trading prices, KIARF is priced at $0.01, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, KIARF's ROE is -1.47%, compared to SDGCF's ROE of +0.05%. Regarding short-term risk, KIARF and SDGCF have similar daily volatility (0.00).
KIARF vs SHPPF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SHPPF has a market cap of 3.01B. Regarding current trading prices, KIARF is priced at $0.01, while SHPPF trades at $148.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SHPPF's P/E ratio is -58.58. In terms of profitability, KIARF's ROE is -1.47%, compared to SHPPF's ROE of -0.09%. Regarding short-term risk, KIARF is less volatile compared to SHPPF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs SAEYY Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SAEYY has a market cap of 2.99B. Regarding current trading prices, KIARF is priced at $0.01, while SAEYY trades at $14.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SAEYY's P/E ratio is -58.80. In terms of profitability, KIARF's ROE is -1.47%, compared to SAEYY's ROE of -0.09%. Regarding short-term risk, KIARF is less volatile compared to SAEYY. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs SGIPF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SGIPF has a market cap of 2.95B. Regarding current trading prices, KIARF is priced at $0.01, while SGIPF trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SGIPF's P/E ratio is 20.11. In terms of profitability, KIARF's ROE is -1.47%, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, KIARF and SGIPF have similar daily volatility (0.00).
KIARF vs TSUSF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, TSUSF has a market cap of 2.68B. Regarding current trading prices, KIARF is priced at $0.01, while TSUSF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas TSUSF's P/E ratio is 16.87. In terms of profitability, KIARF's ROE is -1.47%, compared to TSUSF's ROE of +0.09%. Regarding short-term risk, KIARF is less volatile compared to TSUSF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs HTSUY Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, HTSUY has a market cap of 2.32B. Regarding current trading prices, KIARF is priced at $0.01, while HTSUY trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas HTSUY's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to HTSUY's ROE of +0.08%. Regarding short-term risk, KIARF is less volatile compared to HTSUY. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs BJTRF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, BJTRF has a market cap of 542.78M. Regarding current trading prices, KIARF is priced at $0.01, while BJTRF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas BJTRF's P/E ratio is 8.10. In terms of profitability, KIARF's ROE is -1.47%, compared to BJTRF's ROE of +0.03%. Regarding short-term risk, KIARF is less volatile compared to BJTRF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs ZRSEF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, ZRSEF has a market cap of 499.65M. Regarding current trading prices, KIARF is priced at $0.01, while ZRSEF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas ZRSEF's P/E ratio is -2.14. In terms of profitability, KIARF's ROE is -1.47%, compared to ZRSEF's ROE of -0.26%. Regarding short-term risk, KIARF is less volatile compared to ZRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs NVACF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, NVACF has a market cap of 78.47M. Regarding current trading prices, KIARF is priced at $0.01, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas NVACF's P/E ratio is 31.60. In terms of profitability, KIARF's ROE is -1.47%, compared to NVACF's ROE of +0.06%. Regarding short-term risk, KIARF is less volatile compared to NVACF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs HTPRF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, HTPRF has a market cap of 11.86M. Regarding current trading prices, KIARF is priced at $0.01, while HTPRF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas HTPRF's P/E ratio is -0.06. In terms of profitability, KIARF's ROE is -1.47%, compared to HTPRF's ROE of +0.11%. Regarding short-term risk, KIARF and HTPRF have similar daily volatility (0.00).
KIARF vs PNPL Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, PNPL has a market cap of 7.31M. Regarding current trading prices, KIARF is priced at $0.01, while PNPL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas PNPL's P/E ratio is -10.00. In terms of profitability, KIARF's ROE is -1.47%, compared to PNPL's ROE of +0.54%. Regarding short-term risk, KIARF and PNPL have similar daily volatility (0.00).
KIARF vs FFLWF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, FFLWF has a market cap of 5.42M. Regarding current trading prices, KIARF is priced at $0.01, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, KIARF's ROE is -1.47%, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, KIARF is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs RLLVF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, RLLVF has a market cap of 5.28M. Regarding current trading prices, KIARF is priced at $0.01, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, KIARF's ROE is -1.47%, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, KIARF and RLLVF have similar daily volatility (0.00).
KIARF vs HEWA Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, HEWA has a market cap of 4.18M. Regarding current trading prices, KIARF is priced at $0.01, while HEWA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas HEWA's P/E ratio is -3.27. In terms of profitability, KIARF's ROE is -1.47%, compared to HEWA's ROE of +0.08%. Regarding short-term risk, KIARF is less volatile compared to HEWA. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs LGNZZ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, LGNZZ has a market cap of 2.70M. Regarding current trading prices, KIARF is priced at $0.01, while LGNZZ trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to LGNZZ's ROE of -0.16%. Regarding short-term risk, KIARF and LGNZZ have similar daily volatility (0.00).
KIARF vs GABLF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, GABLF has a market cap of 2.66M. Regarding current trading prices, KIARF is priced at $0.01, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas GABLF's P/E ratio is -0.04. In terms of profitability, KIARF's ROE is -1.47%, compared to GABLF's ROE of +2.91%. Regarding short-term risk, KIARF and GABLF have similar daily volatility (0.00).
KIARF vs SYDRF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SYDRF has a market cap of 2.33M. Regarding current trading prices, KIARF is priced at $0.01, while SYDRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SYDRF's P/E ratio is 8.00. In terms of profitability, KIARF's ROE is -1.47%, compared to SYDRF's ROE of +0.96%. Regarding short-term risk, KIARF is less volatile compared to SYDRF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs IWINF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, IWINF has a market cap of 1.68M. Regarding current trading prices, KIARF is priced at $0.01, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas IWINF's P/E ratio is -0.06. In terms of profitability, KIARF's ROE is -1.47%, compared to IWINF's ROE of -0.77%. Regarding short-term risk, KIARF and IWINF have similar daily volatility (0.00).
KIARF vs NUTTQ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, NUTTQ has a market cap of 1.07M. Regarding current trading prices, KIARF is priced at $0.01, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, KIARF is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs LGNYZ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, LGNYZ has a market cap of 771768.00. Regarding current trading prices, KIARF is priced at $0.01, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to LGNYZ's ROE of -0.16%. Regarding short-term risk, KIARF and LGNYZ have similar daily volatility (0.00).
KIARF vs RADCQ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, RADCQ has a market cap of 559740.00. Regarding current trading prices, KIARF is priced at $0.01, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, KIARF's ROE is -1.47%, compared to RADCQ's ROE of +0.94%. Regarding short-term risk, KIARF is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs AEGY Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, AEGY has a market cap of 411180.00. Regarding current trading prices, KIARF is priced at $0.01, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas AEGY's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to AEGY's ROE of +0.00%. Regarding short-term risk, KIARF is less volatile compared to AEGY. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs IPAH Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, IPAH has a market cap of 273628.00. Regarding current trading prices, KIARF is priced at $0.01, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas IPAH's P/E ratio is -0.05. In terms of profitability, KIARF's ROE is -1.47%, compared to IPAH's ROE of -0.82%. Regarding short-term risk, KIARF is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs ETBI Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, ETBI has a market cap of 253974.00. Regarding current trading prices, KIARF is priced at $0.01, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas ETBI's P/E ratio is -0.01. In terms of profitability, KIARF's ROE is -1.47%, compared to ETBI's ROE of +0.00%. Regarding short-term risk, KIARF and ETBI have similar daily volatility (0.00).
KIARF vs FOGCF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, FOGCF has a market cap of 97176.00. Regarding current trading prices, KIARF is priced at $0.01, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas FOGCF's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, KIARF is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs MDIN Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, MDIN has a market cap of 90309.00. Regarding current trading prices, KIARF is priced at $0.01, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas MDIN's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to MDIN's ROE of +0.36%. Regarding short-term risk, KIARF is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs LGNDZ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, LGNDZ has a market cap of 73318.00. Regarding current trading prices, KIARF is priced at $0.01, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to LGNDZ's ROE of -0.16%. Regarding short-term risk, KIARF is less volatile compared to LGNDZ. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs OXIHF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, OXIHF has a market cap of 65725.00. Regarding current trading prices, KIARF is priced at $0.01, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas OXIHF's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, KIARF is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs IMMB Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, IMMB has a market cap of 57497.00. Regarding current trading prices, KIARF is priced at $0.01, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas IMMB's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to IMMB's ROE of -0.09%. Regarding short-term risk, KIARF and IMMB have similar daily volatility (0.00).
KIARF vs HADV Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, HADV has a market cap of 48284.00. Regarding current trading prices, KIARF is priced at $0.01, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas HADV's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to HADV's ROE of +0.83%. Regarding short-term risk, KIARF is less volatile compared to HADV. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs DECN Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, DECN has a market cap of 35450.00. Regarding current trading prices, KIARF is priced at $0.01, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas DECN's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to DECN's ROE of +0.00%. Regarding short-term risk, KIARF and DECN have similar daily volatility (0.00).
KIARF vs SPPH Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SPPH has a market cap of 29436.00. Regarding current trading prices, KIARF is priced at $0.01, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SPPH's P/E ratio is -0.03. In terms of profitability, KIARF's ROE is -1.47%, compared to SPPH's ROE of -0.50%. Regarding short-term risk, KIARF is less volatile compared to SPPH. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs LGNXZ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, LGNXZ has a market cap of 29134.00. Regarding current trading prices, KIARF is priced at $0.01, while LGNXZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas LGNXZ's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to LGNXZ's ROE of -0.16%. Regarding short-term risk, KIARF and LGNXZ have similar daily volatility (0.00).
KIARF vs WPHM Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, WPHM has a market cap of 23223.00. Regarding current trading prices, KIARF is priced at $0.01, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas WPHM's P/E ratio is -0.01. In terms of profitability, KIARF's ROE is -1.47%, compared to WPHM's ROE of -1.56%. Regarding short-term risk, KIARF is less volatile compared to WPHM. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs CAFS Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, CAFS has a market cap of 19883.00. Regarding current trading prices, KIARF is priced at $0.01, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas CAFS's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to CAFS's ROE of +1.94%. Regarding short-term risk, KIARF and CAFS have similar daily volatility (0.00).
KIARF vs SCRCQ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SCRCQ has a market cap of 14074.00. Regarding current trading prices, KIARF is priced at $0.01, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, KIARF's ROE is -1.47%, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, KIARF is less volatile compared to SCRCQ. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs TSTS Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, TSTS has a market cap of 12754.00. Regarding current trading prices, KIARF is priced at $0.01, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas TSTS's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to TSTS's ROE of +2.32%. Regarding short-term risk, KIARF is less volatile compared to TSTS. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs IXSBF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, IXSBF has a market cap of 12627.00. Regarding current trading prices, KIARF is priced at $0.01, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, KIARF's ROE is -1.47%, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, KIARF is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs VIAP Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, VIAP has a market cap of 10279.00. Regarding current trading prices, KIARF is priced at $0.01, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas VIAP's P/E ratio is -0.05. In terms of profitability, KIARF's ROE is -1.47%, compared to VIAP's ROE of +0.65%. Regarding short-term risk, KIARF is less volatile compared to VIAP. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs OMHE Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, OMHE has a market cap of 9828.00. Regarding current trading prices, KIARF is priced at $0.01, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas OMHE's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to OMHE's ROE of +0.73%. Regarding short-term risk, KIARF is less volatile compared to OMHE. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs ALST Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, ALST has a market cap of 8449.00. Regarding current trading prices, KIARF is priced at $0.01, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas ALST's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to ALST's ROE of +0.13%. Regarding short-term risk, KIARF is less volatile compared to ALST. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs HBOSF Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, HBOSF has a market cap of 7780.00. Regarding current trading prices, KIARF is priced at $0.01, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, KIARF's ROE is -1.47%, compared to HBOSF's ROE of +6.73%. Regarding short-term risk, KIARF and HBOSF have similar daily volatility (0.00).
KIARF vs PXYN Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, PXYN has a market cap of 6347.00. Regarding current trading prices, KIARF is priced at $0.01, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas PXYN's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to PXYN's ROE of -0.20%. Regarding short-term risk, KIARF is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs IYXI Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, IYXI has a market cap of 5311.00. Regarding current trading prices, KIARF is priced at $0.01, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas IYXI's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to IYXI's ROE of +1.71%. Regarding short-term risk, KIARF and IYXI have similar daily volatility (0.00).
KIARF vs CNBI Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, CNBI has a market cap of 3815.00. Regarding current trading prices, KIARF is priced at $0.01, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas CNBI's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to CNBI's ROE of +0.17%. Regarding short-term risk, KIARF and CNBI have similar daily volatility (0.00).
KIARF vs NEWG Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, NEWG has a market cap of 2260.00. Regarding current trading prices, KIARF is priced at $0.01, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas NEWG's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to NEWG's ROE of +0.40%. Regarding short-term risk, KIARF is less volatile compared to NEWG. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs FSPM Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, FSPM has a market cap of 1259.00. Regarding current trading prices, KIARF is priced at $0.01, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas FSPM's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to FSPM's ROE of N/A. Regarding short-term risk, KIARF and FSPM have similar daily volatility (0.00).
KIARF vs GRPI Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, GRPI has a market cap of 1043.00. Regarding current trading prices, KIARF is priced at $0.01, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas GRPI's P/E ratio is -0.02. In terms of profitability, KIARF's ROE is -1.47%, compared to GRPI's ROE of +0.09%. Regarding short-term risk, KIARF and GRPI have similar daily volatility (0.00).
KIARF vs RBII Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, RBII has a market cap of 499.00. Regarding current trading prices, KIARF is priced at $0.01, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas RBII's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to RBII's ROE of -0.04%. Regarding short-term risk, KIARF and RBII have similar daily volatility (0.00).
KIARF vs AXMP Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, AXMP has a market cap of 409.00. Regarding current trading prices, KIARF is priced at $0.01, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas AXMP's P/E ratio is 0.00. In terms of profitability, KIARF's ROE is -1.47%, compared to AXMP's ROE of N/A. Regarding short-term risk, KIARF and AXMP have similar daily volatility (0.00).
KIARF vs ACGJ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, ACGJ has a market cap of 324.00. Regarding current trading prices, KIARF is priced at $0.01, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, KIARF's ROE is -1.47%, compared to ACGJ's ROE of N/A. Regarding short-term risk, KIARF and ACGJ have similar daily volatility (0.00).
KIARF vs MDVLQ Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, MDVLQ has a market cap of 161.00. Regarding current trading prices, KIARF is priced at $0.01, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, KIARF is less volatile compared to MDVLQ. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs ISHI Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, ISHI has a market cap of 5.00. Regarding current trading prices, KIARF is priced at $0.01, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas ISHI's P/E ratio is N/A. In terms of profitability, KIARF's ROE is -1.47%, compared to ISHI's ROE of N/A. Regarding short-term risk, KIARF is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for KIARF.
KIARF vs SYNI Comparison
KIARF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KIARF stands at 66.58M. In comparison, SYNI has a market cap of 3.00. Regarding current trading prices, KIARF is priced at $0.01, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KIARF currently has a P/E ratio of -0.01, whereas SYNI's P/E ratio is -0.00. In terms of profitability, KIARF's ROE is -1.47%, compared to SYNI's ROE of N/A. Regarding short-term risk, KIARF and SYNI have similar daily volatility (0.00).